2024 Emerging Cancer Diagnostic Tests and Strategic Assessments of Leading Suppliers
This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.The report includes an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in , collaborative arrangements and business strategies.Contains 286 pages and 28 tables
More Publications
2023 Bio-Rad Diagnostics Market Shares and Competitive Position by Product and Country-Performance, Capabilities, Goals and Strategies
US$ 1,450.00
February 2023
-
2019 Hematology and Flow Cytometry Market: Supplier Shares by Product and Country, Instrumentation Review - Operating Characteristics, Features and Selling Prices of High-, Medium-, and Low-Volume/POC Analyzers
US$ 1,850.00
March 2019
40 pages
2017 Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US
US$ 31,275.00
March 2017
1200 pages
Nucleic Acid Testing (NAT) Instrumentation, Country Market Shares, Strategic Profiles of Leading Suppliers, 2019
US$ 3,850.00
July 2019
129 pages
2015 Strategies in the German Hospital Hemostasis Testing Market
US$ 3,120.00
February 2015
394 pages
